Efficacy and Safety Study of Enzalutamide in Combination With Exemestane in Patients With Advanced Breast Cancer
This study is ongoing, but not recruiting participants.
Astellas Pharma Inc
Medivation is now a wholly owned subsidiary of Pfizer Inc.
Information provided by (Responsible Party):
First received: December 3, 2013
Last updated: December 5, 2016
Last verified: December 2016
No Study Results Posted on ClinicalTrials.gov for this Study
|Study Status:||This study is ongoing, but not recruiting participants.|
|Estimated Study Completion Date:||June 2017|
|Estimated Primary Completion Date:||April 2017 (Final data collection date for primary outcome measure)|